MarketBeatFri, 05 Jun 2026 00:05:13 GMTAkebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones NearAKBA+0.47%
Seeking AlphaThu, 07 May 2026 19:51:25 GMTAkebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call TranscriptAKBA+0.47%
Zacks Investment ResearchThu, 07 May 2026 13:51:03 GMTAkebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue EstimatesAKBA+0.47%
Seeking AlphaThu, 02 Apr 2026 20:52:05 GMTAkebia Therapeutics, Inc. (AKBA) Discusses Pipeline Progress and Strategic Focus on Kidney Disease Treatments at R&D Day TranscriptAKBA+0.47%
